In vivo evidence for brain mitochondrial dysfunction in animal models of Huntington disease (HD) is scarce. We applied the novel 17O magnetic resonance spectroscopy (MRS) technique on R6/2 mice to directly determine rates of oxygen consumption (CMRO2) and assess mitochondrial function in vivo. Basal respiration and maximal CMRO2 in the presence of the mitochondrial uncoupler dinitrophenol (DNP) were compared using 16.4 T in isoflurane anesthetized wild type (WT) and HD mice at 9 weeks. At rest, striatal CMRO2 of R6/2 mice was equivalent to that of WT, indicating comparable mitochondrial output despite onset of motor symptoms in R6/2. After DNP injection, the maximal CMRO2 in both striatum and cortex of R6/ 2 mice was significantly lower than that of WT, indicating less spare energy generating capacity. In a separate set of mice, oligomycin injection to block ATP generation decreased CMRO2 equally in brains of R6/2 and WT mice, suggesting oxidative phosphorylation capacity and respiratory coupling were equivalent at rest. Expression levels of representative mitochondrial proteins were compared from harvested tissue samples. Significant differences between R6/2 and WT included: in striatum, lower VDAC and the mitochondrially encoded cytochrome oxidase subunit I relative to actin; in cortex, lower tricarboxylic acid cycle enzyme aconitase and higher protein carbonyls; in both, lower glycolytic enzyme enolase. Therefore in R6/2 striatum, lowered CMRO2 may be attributed to a decrease in mitochondria while the cortical CMRO2 decrease may result from constraints upstream in energetic pathways, suggesting regionally specific changes and possibly rates of metabolic impairment.
|Original language||English (US)|
|Number of pages||14|
|Journal||Human molecular genetics|
|State||Published - 2016|
Bibliographical noteFunding Information:
We would like to acknowledge prior support from the Winston and Maxine Wallin Neuroscience Discovery Fund for validation of the 17O MRS method, without which the current project would not have been feasible. This work was supported by CHDI, Inc. [A-7107 to JMD] and National Institutes of Health [2P41EB015894 to LEE]. The Center for MR Research is supported by the National Institute of Biomedical Imaging and Bioengineering [P41 EB015894], the Institutional Center Cores for Advanced Neuroimaging [P30 NS076408] and National Center for Research Resources (NCRR) [S10 RR025031].
© The Author 2016. Published by Oxford University Press.